A study to investigate tmp-301 treatment in adult patients with alcohol use disorder (H-56266)

A phase 2, randomized, investigator and participant blinded, placebo-controlled, parallel-group study to investigate the safety, tolerability, and preliminary efficacy of tmp-301 treatment in adult patients with alcohol use disorder (AUD)

Hope is here for those struggling with Alcohol Use Disorder

Alcohol use disorder can be a difficult condition to live with, and although many Americans have it, there are few available treatment options. We’re looking to change that.

Learn more about this clinical trial that could help those with Alcohol Use Disorder and be a part of advancing research that could help others

Who is this study for?

If you:

• Want to reduce or stop drinking alcohol
• Are 18-65 years old
• Struggle with moderate to severe alcohol use

What’s involved?

• You would take the investigational medication, or placebo, for 14weeks or just over 3 months
• You will have up to 17 visits, including regular weekly check-ins during the 14-week treatment phase.

Your time and effort will be compensated, and free Uber Health transportation is available